Roshani Patel, Michael Emanuel, Ryan Young, Elizabeth M. Hill. "A phase 1b/2 study of mirdametinib in combination with sirolimus for patients with RAS-mutated relapsed/refractory multiple myeloma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps7582